LimmaTech Biologics AG’s $37 Million Series A Financing Round

Marco Zingaro
Tagged:

VISCHER acted as legal advisor to LimmaTech Biologics in the transaction.LimmaTech Biologics AG closed a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here